New Flyer Industries Inc.

NFI-T

It's one of the cheapest TSX stocks. They made a few missteps, like order delays, but they will iron them out. They made a big UK acquisition. A good moat around it with few competitors. A very stable market for replacement buses. NFI also leads in e-buses. Trades at a low 10x PE. This will do well in the long run.

It hasn't performed well lately; it'll bottom in the $20's. Likes it now, because they're positioned well in the bus sector. What's interesting is that they're branching away from diesel into electric buses--the future. They're ahead of the curve. It's not a large-cap stock, so don't throw a lot of money into it, but it's a good entry point now. (Analysts’ price target is $38.50)

Continued urbanization will help NFI. Also, more people need public transit in North American cities. NFI is a leader in the zero-emissions electric buses and this space will continue to grow for years as cities want greener transportation. NFI has been pressured for the past year, because of lower guidance and orders. This is a great long-term opportunity. Pays a yield over 5% at a cash flow yield of 10%. (Analysts’ price target is $38.50)

(A Top Pick Aug 08/18, Down 47%) He sold and minimized his losses and kept the money in cash. He always uses stops. Don't buy it now.

One problem is free cash flow is down 13%, and gross margins were down. Private coach business declining, parts business under pressure. Huge dividend for a cyclical company. Last numbers disappointed. Wait a bit for it to go sideways before putting money in.

She expects them to be reporting earnings in the next couple of days. This bus manufacturing company has made a purchase in the US for double-decker buses. This is not a great growth sector. She wants to see how the recent acquisition plays out.

It's in a long-term downtrend with strong resistance at $30. If markets re-accelerate, sell it--once it bounces back to $30, it will resume its downtrend. More downside is coming.

They've grown their US business a lot, though recently acquired in the UK. Recently, the stock and their reports have disappointed. The next quarters will be rocky, but globally more people are taking transit, which is positive. A well-run business. You can buy it cheaply now and it's worth a look.

He sold it last year, concerned that the cycle was rolling over, based on several company metrics. They had a good 5-year run of organic growth and ended. They have a string of earnings missings and the market is punishing it. That said, the 6.5% dividend is safe, but this isn't enough to own this stock.

The stock got way over done and the valuation was too expensive. A well run company, but not one he would buy. He needs to see it trade near 8 times earnings -- not 30 times.

It pays $1.70 per share in distribution with cash flow near $3.00 per share so the payout ratio is reasonable. The company has been hard hit lately and he was taking some profit at $50 per share. Much of their orders are based on municipal budgets, which makes their orders unpredictable in this economic environment. He thinks it is more of a buy than a sell today.

For an RRSP, even though it's trending down? He used to own it. They were a market darling until they hit weaker markets and execution problems. NFI is still a good company and the yield is attractive, but he's unsure if it will get cut.

Quarter reported lower, so stock's down a bit. Business is fundamentally strong, still growing. Will benefit from urbanization. Trading at a low multiple. Defensive way to play the industrial space right now. Yield is 5.44%. (Analysts’ price target is $40.00)

2019 forecast cut? They cut the guidance by 3.4% and the stock is down 10%. He thinks this was overly punitive. They just completed a UK acquisition that he likes and the dividend is solid. They just bought more in the past few months and will buy more when he gets back to his desk. The trend in urbanization continues to increase and this is the fastest, low cost method for increasing transportation. Their recent issues will be transient.